Improved early clinical development through human microdosing studies
- 1 July 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 10 (13), 890-894
- https://doi.org/10.1016/s1359-6446(05)03509-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Less is more: the human microdosing conceptDrug Discovery Today, 2005
- Big physics, small doses: the use of AMS and PET in human microdosing of development drugsNature Reviews Drug Discovery, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Trends in development cyclesNature Reviews Drug Discovery, 2002
- The Value of Improving the Productivity of the Drug Development ProcessPharmacoEconomics, 2002
- The Use of In Vitro Methods to Predict In Vivo Pharmacokinetics and Drug InteractionsCurrent Drug Metabolism, 2001
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical FirmsDrug Information Journal, 2000
- Innovation Deficit in the Pharmaceutical IndustryDrug Information Journal, 1996
- Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).British Journal of Clinical Pharmacology, 1988